Treatment of Low-Risk Pulmonary Embolism with Pulmonary Infarction
For low-risk PE with pulmonary infarction, initiate anticoagulation with a NOAC (apixaban, dabigatran, edoxaban, or rivaroxaban) and strongly consider hospitalization rather than outpatient management, despite the low-risk classification.
Key Treatment Algorithm
Step 1: Initiate Anticoagulation Immediately
Start a NOAC as first-line therapy 1:
- Preferred agents: Apixaban, rivaroxaban (single-drug regimens), edoxaban, or dabigatran
- Alternative: LMWH or fondaparinux if parenteral initiation needed, then transition to oral anticoagulation 1
- Avoid NOACs if: Severe renal impairment (eGFR <30 mL/min), pregnancy/lactation, or antiphospholipid antibody syndrome 1
Step 2: Address the Pulmonary Infarction Complication
The presence of pulmonary infarction is a critical caveat that substantially impacts disposition decisions:
- Pulmonary infarction was the primary reason for hospitalization in 92% of otherwise low-risk PE patients in one prospective study 2
- Patients with infarction often experience severe pain requiring opiates, which is an explicit exclusion criterion for outpatient management 3
- Infarction may be associated with fever and elevated inflammatory markers (CRP), requiring monitoring 4
Therefore, even with low-risk scores (sPESI=0, PESI class I-II), pulmonary infarction typically necessitates initial hospitalization for:
- Pain management (often requiring parenteral analgesia)
- Monitoring for complications (pleural effusion, hemoptysis)
- Ensuring hemodynamic stability over 24-48 hours
Step 3: Risk Stratification Confirmation
Before any discharge consideration, verify true low-risk status 1:
- Hemodynamically stable (no hypotension, shock)
- PESI class I-II or sPESI = 0
- Normal cardiac biomarkers (troponin, NT-proBNP/BNP)
- No RV dysfunction on echocardiography or CT (normal RV:LV ratio)
- Adequate cardiopulmonary reserve
Step 4: Disposition Decision
For low-risk PE WITH pulmonary infarction:
Initial hospitalization is recommended for observation (24-48 hours minimum) because:
- Pain control requirements 3
- Need to monitor for hemodynamic deterioration 1
- Risk of complications from infarction itself
Early discharge (within 24-48 hours) can be considered once 1, 5:
- Pain is controlled with oral medications
- Patient remains hemodynamically stable
- No fever or signs of infection
- Patient meets all standard low-risk criteria
- Adequate outpatient follow-up is arranged
For low-risk PE WITHOUT pulmonary infarction:
- Outpatient management is appropriate if all low-risk criteria met and proper systems in place 1, 5, 3
Important Clinical Pitfalls
Common Mistake: Automatic Outpatient Treatment for "Low-Risk" PE
The presence of pulmonary infarction overrides low-risk scoring systems for initial disposition. While guidelines support outpatient management of low-risk PE 1, 5, real-world data shows that pulmonary infarction creates symptoms and complications requiring hospital-level care 2.
Contraindications to Outpatient Management 3
Even without infarction, do NOT discharge if:
- Recent bleeding or high bleeding risk
- Severe pain requiring opiates
- CKD stage 4-5 (eGFR <30)
- Severe liver disease
- Social barriers (no home support, communication issues, compliance concerns)
- Already on full anticoagulation when PE occurred
Monitoring Requirements
If early discharge is pursued 1, 3:
- Arrange follow-up within 24-72 hours
- Ensure 24/7 access to emergency care
- Confirm patient understanding of warning signs
- Verify medication access and affordability
- Consider involving general practitioner in care coordination 2
Anticoagulation Specifics
NOAC dosing (choose ONE regimen):
- Apixaban: 10 mg twice daily × 7 days, then 5 mg twice daily (no parenteral lead-in needed)
- Rivaroxaban: 15 mg twice daily × 21 days, then 20 mg once daily (no parenteral lead-in needed)
- Edoxaban: Requires LMWH/fondaparinux × 5-10 days first, then 60 mg once daily
- Dabigatran: Requires LMWH/fondaparinux × 5-10 days first, then 150 mg twice daily
Duration: Minimum 3 months for all patients 1
Evidence Quality Note
The 2019 ESC Guidelines 1 provide Class I, Level A recommendations for NOAC use and Class IIa, Level A recommendations for early discharge in carefully selected low-risk PE patients. However, none of the major guidelines specifically address pulmonary infarction as a modifier of outpatient eligibility. The evidence showing 92% hospitalization rates for low-risk PE with infarction 2 reflects real-world clinical practice where symptom severity (particularly pain) drives admission decisions regardless of prognostic scores.
The safest approach: Admit patients with pulmonary infarction for initial stabilization and pain control, then pursue early discharge once symptoms are controlled and stability confirmed.